Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 20/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.67 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.67 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2575316 | 0.90 | MET (0.72) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL2565839 | 0.90 | MET (1.00) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL2574063 | 0.90 | MET (0.81) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL2572667 | 0.90 | MET (0.81) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL2569486 | 0.89 | MET (0.77) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL28641131 | 0.88 | MET (0.79) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL30948868 | 0.88 | MET (0.75) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL22109390 | 0.88 | MET (0.75) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL12121796 | 0.86 | MET (0.61) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL2574785 | 0.86 | MET (0.76) | METCYP2C9PDE3BPDE3APDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2018383-B1 | TRIAZOLOPYRAZINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS | PFIZER PROD INC (US) | 2011-11-09 | — | — | EP | disclosed |